Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2025 Earnings Call Transcript November 8, 2025
Operator: Thank you for standing by. Welcome to Ligand Third Quarter 2025 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Melanie Herman. Please go ahead.
Melanie Herman: Good morning, everyone, and welcome to Ligand’s Third Quarter 2025 Earnings Call. During the call today, we will review the financial results we released earlier today and provide...
